Novartis reported CHF34.24B in Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Alcon AG ALC:SW 4.5B 9M
Amgen AMGN:US $ 37579M 4797M
AstraZeneca AZN:LN 31912M 4417M
Bayer BAYN:GR € 41766M 1394M
Biogen BIIB:US $ 7271.1M 1.9M
Bristol Myers Squibb BMY:US $ 44742M 416M
Eli Lilly And LLY:US $ 17085.4M 570.3M
Fresenius FRE:GR € 27191M 98M
Fresenius Medical Care FME:GR € 13227M 111.48M
Galapagos GLPG:NA € 26.39M 1.52M
Genmab GEN:DC DK 437M 6M
GlaxoSmithKline GSK:LN 25605M 122M
GRIFOLS GRF:SM € 7933.89M 565.82M
H. Lundbeck A/S LUN:DC 5.58B 211M
Hikma Pharmaceutical HIK:LN 932M 0
Lonza Group LONN:SW 3.65B 67M
Merck MRK:GR € 10965M 1034M
Novartis NOVN:VX SF 34243M 1526M
Novartis NVS:US $ 34243M 1526M
Orion ORNBV:FH € 108M 0.2M
Philips PHIA:NA € 7634M 197M
Recordati REC:IM € 1066.35M 81.21M
Regeneron Pharmaceuticals REGN:US $ 2698.6M 1M